Enovis (ENOV) Depreciation & Amortization (CF) (2011 - 2026)
Enovis' (ENOV) quarterly Depreciation & Amortization (CF) came in at $73.4 million in Q2 2026, up 2.69% year-on-year from $71.4 million in Q2 2025, and down 4.75% on a QoQ basis from $77.0 million in Q4 2025.
Enovis (ENOV) Depreciation & Amortization (CF) (2011 - 2026) Analysis & Trends
Enovis (ENOV) has 16 years of Depreciation & Amortization (CF) data on file, last reported at $73.4 million in Q2 2026.
- On a quarterly basis, Depreciation & Amortization (CF) rose 2.69% year-over-year to $73.4 million in Q2 2026; TTM through Apr 2026 was $296.3 million, a 4.76% increase from a year earlier, with the FY2025 full-year figure at $294.4 million, up 3.36% from the prior year.
- Depreciation & Amortization (CF) for Q2 2026 stood at $73.4 million, down from $77.0 million in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for ENOV reached as high as $97.4 million in Q2 2023 and fell as low as $7.6 million in Q1 2023.
- Historically, Depreciation & Amortization (CF) has averaged $64.1 million across 5 years, with a median of $71.2 million in 2024.
- Across the five-year window, Depreciation & Amortization (CF) slumped 88.48% in 2023 and soared 865.08% in 2024, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $52.3 million in 2022, then rose by 8.34% to $56.6 million in 2023, then soared by 31.42% to $74.4 million in 2024, then increased by 3.51% to $77.0 million in 2025, then dropped by 4.75% to $73.4 million in 2026.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $73.4 million in Q2 2026, $77.0 million in Q4 2025, and $74.4 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Enovis | 1.50 Bn | 1.47 Bn | 365.49 Mn | 73.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 73.36 Mn |
| Apr 3, 2026 | 73.36 Mn |
| Dec 31, 2025 | 77.01 Mn |
| Dec 31, 2025 | 77.01 Mn |
| Oct 3, 2025 | 74.38 Mn |
| Oct 3, 2025 | 74.38 Mn |
| Jul 4, 2025 | 71.55 Mn |
| Jul 4, 2025 | 71.55 Mn |
| Apr 4, 2025 | 71.44 Mn |
| Apr 4, 2025 | 71.44 Mn |
| Dec 31, 2024 | 74.40 Mn |
| Dec 31, 2024 | 74.40 Mn |
| Sep 27, 2024 | 71.23 Mn |
| Sep 27, 2024 | 71.23 Mn |
| Jun 28, 2024 | 65.76 Mn |
| Jun 28, 2024 | 65.76 Mn |
| Mar 29, 2024 | 73.40 Mn |
| Mar 29, 2024 | 73.40 Mn |
| Dec 31, 2023 | 56.62 Mn |
| Dec 31, 2023 | 56.62 Mn |